Correlation Between MediciNova and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both MediciNova and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Citius Oncology,, you can compare the effects of market volatilities on MediciNova and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Citius Oncology,.
Diversification Opportunities for MediciNova and Citius Oncology,
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between MediciNova and Citius is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of MediciNova i.e., MediciNova and Citius Oncology, go up and down completely randomly.
Pair Corralation between MediciNova and Citius Oncology,
Given the investment horizon of 90 days MediciNova is expected to generate 1.05 times less return on investment than Citius Oncology,. But when comparing it to its historical volatility, MediciNova is 2.93 times less risky than Citius Oncology,. It trades about 0.19 of its potential returns per unit of risk. Citius Oncology, is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 107.00 in Citius Oncology, on September 15, 2024 and sell it today you would earn a total of 4.00 from holding Citius Oncology, or generate 3.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Citius Oncology,
Performance |
| Timeline |
| MediciNova |
| Citius Oncology, |
MediciNova and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Citius Oncology,
The main advantage of trading using opposite MediciNova and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| MediciNova vs. Puma Biotechnology | MediciNova vs. Iovance Biotherapeutics | MediciNova vs. Day One Biopharmaceuticals | MediciNova vs. Inozyme Pharma |
| Citius Oncology, vs. Molecular Partners AG | Citius Oncology, vs. MediciNova | Citius Oncology, vs. Anebulo Pharmaceuticals | Citius Oncology, vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |